Cart summary

You have no items in your shopping cart.

Recombinant Human FGF9

Recombinant Human FGF9

Catalog Number: orb1921835

DispatchUsually dispatched within 5-10 working days
$ 170.00
Catalog Numberorb1921835
CategoryProteins
DescriptionFibrolast growth factor 9 (FGF9) is an FGF9 subfamily (including FGF9, 16, and 20) member. Unlike other secreted proteins which have a cleavable N-terminal secreted signal peptide, FGF9/16/20 have non-cleaved N-terminal signal peptides. As intercellular signaling molecules, they are involved in a variety of complex responses in animal development. Cardiogenesis is controlled by many members of the transcription factor family. Evidence suggests that FGF signaling, including the FGF9 subfamily, has a pretty close association with these cardiac-specific genes. In addition, recent studies have shown that the FGF9 subfamily maintains functional adaptation and survival after myocardial infarction in adult myocardium. Since FGF9/16/20 are secreted proteins, their function characterization in cardiac regeneration can promote their potential to be developed for the treatment of cardioprotection and revascularization. In the postmyocardial infarction heart, FGF9 promotes cardiomyocyte hypertrophy by activating BMP6 and its downstream targets. FGF9 also activates c-Kit stem cells and enhances angiogenesis in the infracted diabetic heart. In addition, studies have shown that FGF-9 signaling can stimulate mesenchymal cell proliferation and migration of mesonephric cells into the testis during development, contributing to the formation of the interstitial compartment of the testis.
Form/AppearanceLyophilized Powder
Purity≥95%
UniProt IDP31371
MW23.2kDa
Application notesApplication Notes: For research use only. Minimum Sample Size: 50μg/vial
Expression SystemEukaryotic cell
Endotoxins≤10 EU/mg
SourceCHO Cell
Biological OriginHuman
StorageUse a manual defrost freezer and avoid repeated freeze - thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -88°C under sterile conditions after reconstitution.
Alternative namesFibroblast Growth Factor 9, Heparin-Binding Growth
Read more...
NoteFor research use only
Entrez2254
  • Human FGF9 protein (Active) [orb359154]

    > 95% as determined by SDS-PAGE and HPLC.

    23.3 kDa

    E.Coli

    5 μg, 100 μg, 500 μg
  • Human FGF9 protein [orb594735]

    Greater than 95% as determined by SDS-PAGE.

    23.44 kDa

    E.coli

    1 mg, 500 μg, 10 μg, 50 μg
  • Human FGF-9 Protein [orb1471703]

    Greater than 95% as determined by reducing SDS-PAGE.

    23.44 KDa

    Mammalian

    50 μg, 10 μg
  • Human FGF9 protein [orb391739]

    ELISA,  MS,  SDS-PAGE,  WB

    Greater than 95% as determined by SEC-HPLC and reducing SDS-PAGE.

    E. coli

    500 μg, 50 μg, 10 μg
  • Recombinant Human Fibroblast growth factor 9 (FGF9), partial (Active) [orb2657900]

    Greater than 95% as determined by SDS-PAGE.

    23.2 kDa

    Mammalian cell

    10 μg, 1 mg, 50 μg